Publications
Showing 511 to 520 of 555 Publications
Title | Authors | Year | Journal |
---|---|---|---|
Ageism and COVID-19: what does our society’s response say about us? | Fraser, S.*, Lagacé, M*, Bongué, B., Ndeye, N., Guyot, J., Bechard, L.**, Garcia, L., Taler, V., Members of the CCNA Social Inclusion and Stigma Working Group*, Adam, S., Beaulieu, M., Bergeron, C.D., Boudjemadi, V., Desmette, D., Donizzetti, A. R., Éthier, S., Garon, S., Gillis, M., Levasseur, M., Lortie-Lussier, M., Marier, P., Robitaille, A., Sawchuk, K., Lafontaine, C., & Tougas, F. | 2020 | Age and Ageing |
Ageism and COVID-19: what does our society’s response say about us? | Fraser, S.*, Lagacé, M*, Bongué, B., Ndeye, N., Guyot, J., Bechard, L.**, Garcia, L., Taler, V.*, Members of the CCNA Social Inclusion and Stigma Working Group*, Adam, S., Beaulieu, M., Bergeron, C.D., Boudjemadi, V., Desmette, D., Donizzetti, A. R., Éthier, S., Garon, S., Gillis, M., Levasseur, M., Lortie-Lussier, M., Marier, P., Robitaille, A., Sawchuk, K., Lafontaine, C., & Tougas, F. | 2020 | Age and Ageing |
Age-related deregulation of TDP-43 after stroke enhances NF-kappaB-mediated inflammation and neuronal damage | Thammisetty, S.S., Pedragosa, J., Weng, Y.C., Calon, F.**, Planas, A., Kriz, J.** | 2018 | Journal of Neuroinflammation |
Age at Onset of Parkinson’s Disease Among Ashkenazi Jewish Patients: Contribution of Environmental Factors, LRRK2 p.G2019S and GBA p.N370S Mutations | Yahalom G, Rigbi A, Israeli-Korn S, Krohn L, Rudakou U, Ruskey JA, Benshimol L, Tsafnat T, Gan-Or Z*, Hassin-Baer S, Greenbaum L | 2020 | Journal of Parkinson's Disease |
Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria | Ismail, Z., Gatchel, J., Bateman, D. R., Barcelos-Ferreira, R., Chantillon, M., Jaeger, J., Donovan, N. J., & Mortby, M. E. | 2017 | International Psychogeriatrics |
Aerobic Glycolysis Is Required for Spatial Memory Acquisition But Not Memory Retrieval in Mice. | Harris, R.A.**, Lone, A., Lim, H., Martinez, F., Frame, A.K., Scholl, T.J., Cumming, R.C.** | 2019 | eNeuro. |
Aerobic Glycolysis in the Frontal Cortex Correlates with Memory Performance in Wild-Type Mice But Not the APP/PS1 Mouse Model of Cerebral Amyloidosis | Harris, R. A., Tindale, L., Lone, A., Singh, O., Macauley, S. L., Stanley, M., Holtzman, D. M., Bartha, R., & Cumming, R. | 2016 | Journal of Neuroscience |
Abeta34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression. | Liebsch, F., Kulic, L., Teunissen, C., Shobo, A., Ulku, I., Engelschalt, V., Hancock, M.A., van der Flier, W.M., Kunach, P., Rosa-Neto, P.**, Scheltens, P., Poirier, J.**, Saftig, P., Bateman, R.J., Breitner, J.**, Hock, C., Multhaup, G.** | 2019 | Nature communications. |
Abeta-induced vulnerability propagates via the brain’s default mode network. | Pascoal, T.A.*, Mathotaarachchi, S.*, Kang, M.S., Mohaddes, S., Shin, M.*, Park, A.Y., Parent, M.J.*, Benedet, A.L.*, Chamoun, M., Therriault, J., Hwang, H., Cuello, A.C.**, Misic, B., Soucy, J.P.**, Aston, J.A.D., Gauthier, S.**, Rosa-Neto, P** | 2019 | Nature communications. |
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases | Brum, W. S., Cullen, N. C., Janelidze, S., Ashton, N. J., Zimmer, E. R., Therriault, J.**, Benedet, A. L., Rahmouni, N.**, Tissot, C.**, Stevenson, J., Servaes, S., Triana-Baltzer, G., Kolb, H. C., Palmqvist, S., Stomrud, E., Rosa-Neto, P.*, Blennow, K., & Hansson, O | 2023 | Nature aging |
Showing 511 to 520 of 555 Publications